Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study

Given the high rate of postinflammatory hyperpigmentation, non-ablative 1,550 nm fractional laser at 15 mJ/microbeam is not recommendable in the treatment of melasma.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors compared non-ablative 1,550 nm fractional laser therapy with triple topical therapy in a split-face randomized study of 29 patients with melasma. They report that the laser side showed worse hyperpigmentation on physician and instrument measures and lower patient satisfaction, with 31% developing postinflammatory hyperpigmentation, while the topical side showed no significant change.

Participants
29
Who or what was studied
Patients with melasma
Limits stated in the abstract
The abstract reports a small sample of 29 patients and does not describe the blinding or follow-up limits beyond 6 months.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.

Record from PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
550 nm

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Laser, Melanin. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Devices & Dosimetry

Fractional non ablative 675 nm diode laser versus low fluence high frequency Q- switched 1064 nm nd: YAG laser in the treatment of melasma: a comparative split face trial

Adverse events were mild and transient. Fractional non-ablative 675 nm diode laser is more effective and equally safe compared to Q-switched 1064 nm Nd:YAG laser in treating facial melasma, offering a promising modality for patients with recalcitrant hyperpigmentation.

Trial · October 15, 2025 · Bassiony HM et al.